Search

Your search keyword '"Rooney, Cliona M."' showing total 1,438 results
Start Over Author "Rooney, Cliona M."
1,438 results on '"Rooney, Cliona M."'

1. Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target

Author

Mandal, Kamal, Wicaksono, Gianina, Yu, Clinton, Adams, Jarrett J, Hoopmann, Michael R, Temple, William C, Izgutdina, Adila, Escobar, Bonell Patiño, Gorelik, Maryna, Ihling, Christian H, Nix, Matthew A, Naik, Akul, Xie, William H, Hübner, Juwita, Rollins, Lisa A, Reid, Sandy M, Ramos, Emilio, Kasap, Corynn, Steri, Veronica, Serrano, Juan Antonio Camara, Salangsang, Fernando, Phojanakong, Paul, McMillan, Melanie, Gavallos, Victor, Leavitt, Andrew D, Logan, Aaron C, Rooney, Cliona M, Eyquem, Justin, Sinz, Andrea, Huang, Benjamin J, Stieglitz, Elliot, Smith, Catherine C, Moritz, Robert L, Sidhu, Sachdev S, Huang, Lan, and Wiita, Arun P

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Immunology, Cancer, Hematology, Orphan Drug, Gene Therapy, Rare Diseases, Pediatric Cancer, Pediatric, Childhood Leukemia, Genetics, Immunotherapy, Biotechnology, 5.2 Cellular and gene therapies, 5.1 Pharmaceuticals, Humans, Receptors, Chimeric Antigen, T-Lymphocytes, Integrins, Immunotherapy, Adoptive, Leukemia, Myeloid, Acute, Oncology and carcinogenesis
Abstract

Safely expanding indications for cellular therapies has been challenging given a lack of highly cancer-specific surface markers. Here we explore the hypothesis that tumor cells express cancer-specific surface protein conformations that are invisible to standard target discovery pipelines evaluating gene or protein expression, and these conformations can be identified and immunotherapeutically targeted. We term this strategy integrating cross-linking mass spectrometry with glycoprotein surface capture 'structural surfaceomics'. As a proof of principle, we apply this technology to acute myeloid leukemia (AML), a hematologic malignancy with dismal outcomes and no known optimal immunotherapy target. We identify the activated conformation of integrin β2 as a structurally defined, widely expressed AML-specific target. We develop and characterize recombinant antibodies to this protein conformation and show that chimeric antigen receptor T cells eliminate AML cells and patient-derived xenografts without notable toxicity toward normal hematopoietic cells. Our findings validate an AML conformation-specific target antigen and demonstrate a tool kit for applying these strategies more broadly.

Published
2023

6. List Of Contributors

Author

Abraham, Roshini Sarah, primary, Afzali, Behdad, additional, Águeda, Ana, additional, Akin, Cem, additional, Albanesi, Cristina, additional, Antiochos, Brendan, additional, Aranow, Cynthia, additional, Atkinson, John P., additional, Aune, Thomas M., additional, Babu, Subash, additional, Balko, Justin, additional, Ballow, Mark, additional, Bean, Rachel, additional, Belavgeni, Alexia, additional, Berek, Claudia, additional, Beukelman, Timothy, additional, Beziat, Vivien, additional, Bimler, Lynn, additional, Andrew Bird, J., additional, Blutt, Sarah E., additional, Boguniewicz, Mark, additional, Boisson, Bertrand, additional, Boisson-Dupuis, Stéphanie, additional, Borzova, Elena, additional, Bottazzi, Maria, additional, Boyaka, Prosper N., additional, Bridges, John, additional, Browne, Sarah K., additional, Burks, A. Wesley, additional, Bustamante, Jacinta, additional, Casanova, Jean-Laurent, additional, Chan, Alice, additional, Chan, Edwin S.L., additional, Chatham, Walter Winn, additional, Chinen, Javier, additional, Christopher-Stine, Lisa, additional, Coates, Emily, additional, Cope, Andrew P., additional, Corry, David B., additional, Cosme, Joana, additional, Cron, Randy Q., additional, Dalakas, Marinos C., additional, Dann, Sara M., additional, Das, Satya, additional, Daughety, Molly M., additional, Diamond, Betty, additional, Dispenzieri, Angela, additional, Durham, Stephen R., additional, Eagar, Todd N., additional, Al-Hosni, Michelle, additional, Elitzur, Sarah, additional, Elmets, Craig A., additional, Erkan, Doruk, additional, Fleisher, Thomas A., additional, Fonacier, Luz, additional, Fontenot, Andrew P., additional, Fragoulis, George, additional, Francischetti, Ivo M.B., additional, Freiwald, Tilo, additional, Frew, Anthony J., additional, Fujihashi, Kohtaro, additional, Gadina, Massimo, additional, Gapin, Laurent, additional, Gatt, Moshe E., additional, Gershwin, M. Eric, additional, Gillespie, Susan L., additional, Gordon, Lynn K., additional, Goronzy, Jörg J., additional, Grattan, Clive E., additional, Greenspan, Neil S., additional, Gschwend, Anna, additional, Gustafson, Claire E., additional, Hackett, Tillie-Louise, additional, Hamilton, Robert G., additional, Happe, Myra, additional, Harrison, Leonard C., additional, Helbling, Arthur, additional, Heckmann, Emmaline, additional, Hogquist, Kristin, additional, Hohl, Tobias M., additional, Holland, Steven M., additional, Hotez, Peter J., additional, Houser, Katherine, additional, Huntingdon, Nicholas D., additional, Hwangpo, Tracy, additional, Izraeli, Shai, additional, Jaffe, Elaine S., additional, Jalkanen, Sirpa, additional, Java, Anuja, additional, Johnson, Douglas B., additional, Johnson, Tory, additional, Jordan, Michael B., additional, Joshi, Shyam R., additional, Jouanguy, Emmanuelle, additional, Kaminski, Henry J., additional, Kaufmann, Stefan H.E., additional, Khan, David A., additional, Kheradmand, Farrah, additional, Khokar, Dilawar Singh, additional, Khoury, Paneez, additional, Klein, Bruce S., additional, Klion, Amy D., additional, Kohn, Donald B., additional, Kono, Michihito, additional, Korngold, Robert, additional, Koulouri, Vasiliki, additional, Kuhns, Douglas B., additional, Kulkarni, Hrishikesh S., additional, Kuo, Caroline Y., additional, Kusner, Linda L., additional, Lahouti, Arash, additional, Lane, Laura C., additional, Laurence, Arian, additional, Lee, Joyce S., additional, Lee, S. Thera, additional, Leung, Donald Y.M., additional, Levy, Ofer, additional, Lewis, Dorothy E., additional, Li, Evan, additional, Libby, Peter, additional, Lichtman, Andrew H., additional, Linkermann, Andreas, additional, Lionakis, Michail S., additional, Liszewski, M. Kathryn, additional, Lockshin, Michael D., additional, Priel, Debra Long, additional, Lorenz, Adi Zoref, additional, Ludwig, Ralf J., additional, Luong, Amber, additional, Luqmani, Raashid Ahmed, additional, Mackay, Meggan, additional, Mahr, Alfred, additional, Malley, Tamir, additional, Mannon, Elinor C., additional, Mannon, Peter J., additional, Mannon, Roslyn B., additional, Manns, Michael P., additional, Maresso, Anthony, additional, Matson, Scott M., additional, Mavragani, Clio P., additional, Maynard, Craig L., additional, McDonald, Douglas, additional, Meylan, Françoise, additional, Miller, Stephen D., additional, Mitchell, Anna L., additional, Monos, Dimitri S., additional, Mueller, Scott N., additional, Mulders-Manders, Catharina M., additional, Munshi, Pashna N., additional, Murphy, Philip M., additional, Noel, Pierre, additional, Notarangelo, Luigi D., additional, Nunes-Santos, Cristiane J., additional, Nussbaum, Robert L., additional, Nutman, Thomas B., additional, Nutt, Stephen L., additional, O'Neill, Lorraine, additional, O'Shea, John J., additional, Ortel, Thomas L., additional, Pai, Sung-Yun, additional, Paul, Mary E., additional, Pearce, Simon, additional, Peterson, Erik J., additional, Pittaluga, Stefania, additional, Polverino, Francesca, additional, Puck, Jennifer M., additional, Puel, Anne, additional, Radbruch, Andreas, additional, Rajalingam, Raja, additional, Reece, Stephen T., additional, Reveille, John D., additional, Rich, Robert R., additional, Ridley, Lauren K., additional, Romeo, Andrew R., additional, Rooney, Cliona M., additional, Rosen, Antony, additional, Rosenzweig, Sergio, additional, Rouse, Barry T., additional, Rowley, Scott D., additional, Sahiner, Umit Murat, additional, Sakaguchi, Shimon, additional, Salinas, Whitney, additional, Salmi, Marko, additional, Satola, Sarah, additional, Schechter, Marcos, additional, Schmidt, Enno, additional, Schroeder, Harry W., additional, Schwartzberg, Pamela L., additional, Sciumè, Giuseppe, additional, Segal, Benjamin M., additional, Selmi, Carlo, additional, Sharabi, Amir, additional, Shimano, Kristin Ammon, additional, Sikorski, Patricia M., additional, Simon, Anna, additional, Smith, Gideon P., additional, Song, Joo Y., additional, Stephens, David S., additional, Stephens, Robin, additional, Sun, Michel M., additional, Beretta-Piccoli, Benedetta Terziroli, additional, Tonnus, Wulf, additional, Torgerson, Troy R., additional, Torres, Raul Martin, additional, Treat, Jennifer D., additional, Tsokos, George C., additional, Uzel, Gülbü, additional, Uzonna, Jude E., additional, van der Hilst, Jeroen C.H., additional, van der Meer, Jos W.M., additional, Varga, John, additional, Waldman, Meryl, additional, Weatherhead, Jill, additional, Weiser, Peter, additional, Weyand, Cornelia M., additional, Wigley, Fredrick M., additional, Wing, James B., additional, Wood, Kathryn J., additional, Wilde, Shyra, additional, Xu, Hui, additional, Yusuf, Nabiha, additional, Zerbe, Christa S., additional, Zhang, Qian, additional, Ben-Yehuda, Dina, additional, Zhang, Shen-Ying, additional, and Zieske, Arthur W., additional

Published
2023
Full Text
View/download PDF

8. Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs

Author

Steffin, David H.M., Muhsen, Ibrahim N., Hill, LaQuisa C., Ramos, Carlos A., Ahmed, Nabil, Hegde, Meenakshi, Wang, Tao, Wu, Mengfen, Gottschalk, Stephen, Whittle, Sarah B., Lulla, Premal D., Mamonkin, Maksim, Omer, Bilal, Rouce, Rayne H., Heczey, Andras, Metelitsa, Leonid S., Grilley, Bambi J., Robertson, Catherine, Torrano, Virginia, Lapteva, Natalia, Gee, Adrian P., Rooney, Cliona M., Brenner, Malcolm K., and Heslop, Helen E.

Published
2022
Full Text
View/download PDF

9. Epstein Barr virus–positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo

Author

Zhang, Xiaoshan, Zhang, Ran, Ren, Chenghui, Xu, Yi, Wu, Shuhong, Meng, Carrie, Pataer, Apar, Song, Xingzhi, Zhang, Jianhua, Yao, Yixin, He, Hua, Chen, Huiqin, Ma, Wencai, Wang, Jing, Meric-Bernstam, Funda, Champlin, Richard E., Heymach, John V., Rooney, Cliona M., Swisher, Stephen G., Vaporciyan, Ara A., Roth, Jack A., You, M. James, Wang, Michael, and Fang, Bingliang

Published
2022
Full Text
View/download PDF

12. Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study

Author

Kim, Won Seog, Oki, Yasuhiro, Kim, Seok Jin, Yoon, Sang Eun, Ardeshna, Kirit M., Lin, Yi, Ruan, Jia, Porcu, Pierluigi, Brammer, Jonathan E., Jacobsen, Eric D., Yoon, Dok Hyun, Suh, Cheolwon, Suarez, Felipe, Radford, John, Budde, Lihua E., Kim, Jin Seok, Bachy, Emmanuel, Lee, Hun Ju, Bollard, Catherine M., Jaccard, Arnaud, Kang, Hye Jin, Inman, Shannon, Murray, Maryann, Combs, Katherin E., Lee, Daniel Y., Advani, Ranjana, Gunter, Kurt C., Rooney, Cliona M., and Heslop, Helen E.

Published
2021
Full Text
View/download PDF

17. In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin’s Lymphomas

Author

Ramos, Carlos A., Rouce, Rayne, Robertson, Catherine S., Reyna, Amy, Narala, Neeharika, Vyas, Gayatri, Mehta, Birju, Zhang, Huimin, Dakhova, Olga, Carrum, George, Kamble, Rammurti T., Gee, Adrian P., Mei, Zhuyong, Wu, Meng-Fen, Liu, Hao, Grilley, Bambi, Rooney, Cliona M., Heslop, Helen E., Brenner, Malcolm K., Savoldo, Barbara, and Dotti, Gianpietro

Published
2018
Full Text
View/download PDF

22. Phase 1 clinical trial of adoptive immunotherapy using “off-the-shelf” activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia

Author

Boyiadzis, Michael, Agha, Mounzer, Redner, Robert L., Sehgal, Alison, Im, Annie, Hou, Jing-Zhou, Farah, Rafic, Dorritie, Kathleen A., Raptis, Anastasios, Lim, Seah H., Wang, Hong, Lapteva, Natalia, Mei, Zhuyong, Butterfield, Lisa H., Rooney, Cliona M., and Whiteside, Theresa L.

Published
2017
Full Text
View/download PDF

26. Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes

Author

Naik, Swati, Nicholas, Sarah K., Martinez, Caridad A., Leen, Ann M., Hanley, Patrick J., Gottschalk, Steven M., Rooney, Cliona M., Hanson, I. Celine, Krance, Robert A., Shpall, Elizabeth J., Cruz, Conrad R., Amrolia, Persis, Lucchini, Giovanna, Bunin, Nancy, Heimall, Jennifer, Klein, Orly R., Gennery, Andrew R., Slatter, Mary A., Vickers, Mark A., Orange, Jordan S., Heslop, Helen E., Bollard, Catherine M., and Keller, Michael D.

Published
2016
Full Text
View/download PDF

27. Adoptive T-Cell Immunotherapy

Author

Gottschalk, Stephen, Rooney, Cliona M., Compans, Richard W, Series editor, Cooper, Max D., Series editor, Honjo, Tasuku, Series editor, Oldstone, Michael B. A., Series editor, Vogt, Peter K., Series editor, Malissen, Bernard, Series editor, Aktories, Klaus, Series editor, Kawaoka, Yoshihiro, Series editor, Rappuoli, Rino, Series editor, Galan, Jorge E., Series editor, Ahmed, Rafi, Series editor, and Münz, Christian, editor

Published
2015
Full Text
View/download PDF

29. Supplementary Data from A Costimulatory CAR Improves TCR-based Cancer Immunotherapy

Author

Omer, Bilal, primary, Cardenas, Mara G., primary, Pfeiffer, Thomas, primary, Daum, Rachel, primary, Huynh, Mai, primary, Sharma, Sandhya, primary, Nouraee, Nazila, primary, Xie, Cicilyn, primary, Tat, Candise, primary, Perconti, Silvana, primary, Van Pelt, Stacey, primary, Scherer, Lauren, primary, DeRenzo, Chris, primary, Shum, Thomas, primary, Gottschalk, Stephen, primary, Arber, Caroline, primary, and Rooney, Cliona M., primary

Published
2023
Full Text
View/download PDF

30. Data from A Costimulatory CAR Improves TCR-based Cancer Immunotherapy

Author

Omer, Bilal, primary, Cardenas, Mara G., primary, Pfeiffer, Thomas, primary, Daum, Rachel, primary, Huynh, Mai, primary, Sharma, Sandhya, primary, Nouraee, Nazila, primary, Xie, Cicilyn, primary, Tat, Candise, primary, Perconti, Silvana, primary, Van Pelt, Stacey, primary, Scherer, Lauren, primary, DeRenzo, Chris, primary, Shum, Thomas, primary, Gottschalk, Stephen, primary, Arber, Caroline, primary, and Rooney, Cliona M., primary

Published
2023
Full Text
View/download PDF

33. Data from Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells

Author

Shum, Thomas, primary, Omer, Bilal, primary, Tashiro, Haruko, primary, Kruse, Robert L., primary, Wagner, Dimitrios L., primary, Parikh, Kathan, primary, Yi, Zhongzhen, primary, Sauer, Tim, primary, Liu, Daofeng, primary, Parihar, Robin, primary, Castillo, Paul, primary, Liu, Hao, primary, Brenner, Malcolm K., primary, Metelitsa, Leonid S., primary, Gottschalk, Stephen, primary, and Rooney, Cliona M., primary

Published
2023
Full Text
View/download PDF

34. Supplemental Table 1 from Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells

Author

Shum, Thomas, primary, Omer, Bilal, primary, Tashiro, Haruko, primary, Kruse, Robert L., primary, Wagner, Dimitrios L., primary, Parikh, Kathan, primary, Yi, Zhongzhen, primary, Sauer, Tim, primary, Liu, Daofeng, primary, Parihar, Robin, primary, Castillo, Paul, primary, Liu, Hao, primary, Brenner, Malcolm K., primary, Metelitsa, Leonid S., primary, Gottschalk, Stephen, primary, and Rooney, Cliona M., primary

Published
2023
Full Text
View/download PDF

35. Supplemental Figure 4 from Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells

Author

Shum, Thomas, primary, Omer, Bilal, primary, Tashiro, Haruko, primary, Kruse, Robert L., primary, Wagner, Dimitrios L., primary, Parikh, Kathan, primary, Yi, Zhongzhen, primary, Sauer, Tim, primary, Liu, Daofeng, primary, Parihar, Robin, primary, Castillo, Paul, primary, Liu, Hao, primary, Brenner, Malcolm K., primary, Metelitsa, Leonid S., primary, Gottschalk, Stephen, primary, and Rooney, Cliona M., primary

Published
2023
Full Text
View/download PDF

36. Supplemental Figure 3 from Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells

Author

Shum, Thomas, primary, Omer, Bilal, primary, Tashiro, Haruko, primary, Kruse, Robert L., primary, Wagner, Dimitrios L., primary, Parikh, Kathan, primary, Yi, Zhongzhen, primary, Sauer, Tim, primary, Liu, Daofeng, primary, Parihar, Robin, primary, Castillo, Paul, primary, Liu, Hao, primary, Brenner, Malcolm K., primary, Metelitsa, Leonid S., primary, Gottschalk, Stephen, primary, and Rooney, Cliona M., primary

Published
2023
Full Text
View/download PDF

37. Supplemental Figure Legends from Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells

Author

Shum, Thomas, primary, Omer, Bilal, primary, Tashiro, Haruko, primary, Kruse, Robert L., primary, Wagner, Dimitrios L., primary, Parikh, Kathan, primary, Yi, Zhongzhen, primary, Sauer, Tim, primary, Liu, Daofeng, primary, Parihar, Robin, primary, Castillo, Paul, primary, Liu, Hao, primary, Brenner, Malcolm K., primary, Metelitsa, Leonid S., primary, Gottschalk, Stephen, primary, and Rooney, Cliona M., primary

Published
2023
Full Text
View/download PDF

38. Supplemental Figure 1 from Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells

Author

Shum, Thomas, primary, Omer, Bilal, primary, Tashiro, Haruko, primary, Kruse, Robert L., primary, Wagner, Dimitrios L., primary, Parikh, Kathan, primary, Yi, Zhongzhen, primary, Sauer, Tim, primary, Liu, Daofeng, primary, Parihar, Robin, primary, Castillo, Paul, primary, Liu, Hao, primary, Brenner, Malcolm K., primary, Metelitsa, Leonid S., primary, Gottschalk, Stephen, primary, and Rooney, Cliona M., primary

Published
2023
Full Text
View/download PDF

39. Supplemental Figure 5 from Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells

Author

Shum, Thomas, primary, Omer, Bilal, primary, Tashiro, Haruko, primary, Kruse, Robert L., primary, Wagner, Dimitrios L., primary, Parikh, Kathan, primary, Yi, Zhongzhen, primary, Sauer, Tim, primary, Liu, Daofeng, primary, Parihar, Robin, primary, Castillo, Paul, primary, Liu, Hao, primary, Brenner, Malcolm K., primary, Metelitsa, Leonid S., primary, Gottschalk, Stephen, primary, and Rooney, Cliona M., primary

Published
2023
Full Text
View/download PDF

40. Supplemental Figure 2 from Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells

Author

Shum, Thomas, primary, Omer, Bilal, primary, Tashiro, Haruko, primary, Kruse, Robert L., primary, Wagner, Dimitrios L., primary, Parikh, Kathan, primary, Yi, Zhongzhen, primary, Sauer, Tim, primary, Liu, Daofeng, primary, Parihar, Robin, primary, Castillo, Paul, primary, Liu, Hao, primary, Brenner, Malcolm K., primary, Metelitsa, Leonid S., primary, Gottschalk, Stephen, primary, and Rooney, Cliona M., primary

Published
2023
Full Text
View/download PDF

41. Supplemental Figure 6 from Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells

Author

Shum, Thomas, primary, Omer, Bilal, primary, Tashiro, Haruko, primary, Kruse, Robert L., primary, Wagner, Dimitrios L., primary, Parikh, Kathan, primary, Yi, Zhongzhen, primary, Sauer, Tim, primary, Liu, Daofeng, primary, Parihar, Robin, primary, Castillo, Paul, primary, Liu, Hao, primary, Brenner, Malcolm K., primary, Metelitsa, Leonid S., primary, Gottschalk, Stephen, primary, and Rooney, Cliona M., primary

Published
2023
Full Text
View/download PDF

43. Data from T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor–Expressing T Cells

Author

Lapteva, Natalia, primary, Gilbert, Margaret, primary, Diaconu, Iulia, primary, Rollins, Lisa A., primary, Al-Sabbagh, Mina, primary, Naik, Swati, primary, Krance, Robert A., primary, Tripic, Tamara, primary, Hiregange, Manasa, primary, Raghavan, Darshana, primary, Dakhova, Olga, primary, Rouce, Rayne H., primary, Liu, Hao, primary, Omer, Bilal, primary, Savoldo, Barbara, primary, Dotti, Gianpietro, primary, Cruz, Conrad Russel, primary, Sharpe, Keli, primary, Gates, Melissa, primary, Orozco, Aaron, primary, Durett, April, primary, Pacheco, Elizabeth, primary, Gee, Adrian P., primary, Ramos, Carlos A., primary, Heslop, Helen E., primary, Brenner, Malcolm K., primary, and Rooney, Cliona M., primary

Published
2023
Full Text
View/download PDF

44. Supplementary figure legend from Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells

Author

Tanaka, Miyuki, primary, Tashiro, Haruko, primary, Omer, Bilal, primary, Lapteva, Natasha, primary, Ando, Jun, primary, Ngo, Minhtran, primary, Mehta, Birju, primary, Dotti, Gianpietro, primary, Kinchington, Paul R., primary, Leen, Ann M., primary, Rossig, Claudia, primary, and Rooney, Cliona M., primary

Published
2023
Full Text
View/download PDF

45. Supplementary Data from T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor–Expressing T Cells

Author

Lapteva, Natalia, primary, Gilbert, Margaret, primary, Diaconu, Iulia, primary, Rollins, Lisa A., primary, Al-Sabbagh, Mina, primary, Naik, Swati, primary, Krance, Robert A., primary, Tripic, Tamara, primary, Hiregange, Manasa, primary, Raghavan, Darshana, primary, Dakhova, Olga, primary, Rouce, Rayne H., primary, Liu, Hao, primary, Omer, Bilal, primary, Savoldo, Barbara, primary, Dotti, Gianpietro, primary, Cruz, Conrad Russel, primary, Sharpe, Keli, primary, Gates, Melissa, primary, Orozco, Aaron, primary, Durett, April, primary, Pacheco, Elizabeth, primary, Gee, Adrian P., primary, Ramos, Carlos A., primary, Heslop, Helen E., primary, Brenner, Malcolm K., primary, and Rooney, Cliona M., primary

Published
2023
Full Text
View/download PDF

46. Supplementary Table 1 from Interleukin 15 Provides Relief to CTLs from Regulatory T Cell–Mediated Inhibition: Implications for Adoptive T Cell–Based Therapies for Lymphoma

Author

Perna, Serena K., primary, De Angelis, Biagio, primary, Pagliara, Daria, primary, Hasan, Sayyeda T., primary, Zhang, Lan, primary, Mahendravada, Aruna, primary, Heslop, Helen E., primary, Brenner, Malcolm K., primary, Rooney, Cliona M., primary, Dotti, Gianpietro, primary, and Savoldo, Barbara, primary

Published
2023
Full Text
View/download PDF

47. Supplement methodology from Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells

Author

Tanaka, Miyuki, primary, Tashiro, Haruko, primary, Omer, Bilal, primary, Lapteva, Natasha, primary, Ando, Jun, primary, Ngo, Minhtran, primary, Mehta, Birju, primary, Dotti, Gianpietro, primary, Kinchington, Paul R., primary, Leen, Ann M., primary, Rossig, Claudia, primary, and Rooney, Cliona M., primary

Published
2023
Full Text
View/download PDF

48. Supplementary figures 1-2 from Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells

Author

Tanaka, Miyuki, primary, Tashiro, Haruko, primary, Omer, Bilal, primary, Lapteva, Natasha, primary, Ando, Jun, primary, Ngo, Minhtran, primary, Mehta, Birju, primary, Dotti, Gianpietro, primary, Kinchington, Paul R., primary, Leen, Ann M., primary, Rossig, Claudia, primary, and Rooney, Cliona M., primary

Published
2023
Full Text
View/download PDF

49. Supplementary Figures 1-4 from Improving T-cell Therapy for Relapsed EBV-Negative Hodgkin Lymphoma by Targeting Upregulated MAGE-A4

Author

Cruz, Conrad R., primary, Gerdemann, Ulrike, primary, Leen, Ann M., primary, Shafer, Jessica A., primary, Ku, Stephanie, primary, Tzou, Benjamin, primary, Horton, Terzah M., primary, Sheehan, Andrea, primary, Copeland, Amanda, primary, Younes, Anas, primary, Rooney, Cliona M., primary, Heslop, Helen E., primary, and Bollard, Catherine M., primary

Published
2023
Full Text
View/download PDF

50. Supplementary Figure Legend from Interleukin 15 Provides Relief to CTLs from Regulatory T Cell–Mediated Inhibition: Implications for Adoptive T Cell–Based Therapies for Lymphoma

Author

Perna, Serena K., primary, De Angelis, Biagio, primary, Pagliara, Daria, primary, Hasan, Sayyeda T., primary, Zhang, Lan, primary, Mahendravada, Aruna, primary, Heslop, Helen E., primary, Brenner, Malcolm K., primary, Rooney, Cliona M., primary, Dotti, Gianpietro, primary, and Savoldo, Barbara, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results